Amanote Research

Amanote Research

    RegisterSign In

Who Assesses Risk?

Nature - United Kingdom
doi 10.1038/277170c0
Full Text
Open PDF
Abstract

Available in full text

Categories
Multidisciplinary
Date

January 1, 1979

Authors
J. H. FREMLIN
Publisher

Springer Science and Business Media LLC


Related search

Who Is at Risk After Risk Reduction?

Cancer
Cancer ResearchOncology
2018English

Imaging Cell-Mediated Immunity Assesses Acute Myocarditis

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

The Chinese Verbal Learning Test Specifically Assesses Hippocampal State

American Journal of Alzheimer's Disease and other Dementias
GerontologyClinical PsychologyMental HealthGeriatricsPsychiatryNeuroscience
2014English

ACIP Assesses Meningococcal B,HPV, Pneumococcal Vaccines, More

Pharmacy Today
2015English

New Report Assesses Employment Prospects for Scientists and Engineers

Science
MultidisciplinaryPhilosophy of ScienceHistory
1982English

Inpatient Hypoglycaemia: Understanding Who Is at Risk

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Chronic Disease Population Risk Tool (CDPoRT): A Study Protocol for a Prediction Model That Assesses Population-Based Chronic Disease Incidence

Diagnostic and Prognostic Research
2018English

Who Gets Genomic Testing for Breast Cancer Recurrence Risk?

Public Health Genomics
EnvironmentalPublic HealthGeneticsOccupational Health
2013English

Racial Disparity in Birth Defects: Who Has Higher Risk?

Online Journal of Public Health Informatics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy